Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
Hemogenyx Pharmaceuticals has posted its Annual Report and Accounts for the year ending December 31, 2021, alongside the Notice of the Annual General Meeting (AGM) to shareholders. The AGM is scheduled for June 30, 2022, at 2:00 PM BST in London. Key documents, including the 2021 Equity Incentive Plan, are accessible on the company's website. Shareholders can find further details through provided contact information.
- None.
- None.
LONDON, UK / ACCESSWIRE / June 7, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group, confirms that the Annual Report and Accounts for the year ended 31 December 2021, the Notice of the Annual General Meeting ("AGM") and a Form of Proxy were posted to shareholders today and are available on the Company's website at https://hemogenyx.com/investors/annual-and-half-year-reports, and the 2021 Equity Incentive Plan with Non-Employee Sub-Plan (relating to AGM Resolution 5) is available on the Company's website athttps://hemogenyx.com/investors/company-profile/company-information.
The AGM is to be held on 30 June 2022 at 2.00 pm BST at the offices Shakespeare Martineau LLP, 60 Gracechurch Street, London EC3V 0HR.
Enquiries:
Hemogenyx Pharmaceuticals plc | https://hemogenyx.com |
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | headquarters@hemogenyx.com |
Peter Redmond, Director | peter.redmond@hemogenyx.com |
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
Matthew Johnson, Vadim Alexandre, Adam Cowl | |
Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
Lucy Williams, Duncan Vasey, Charles Goodfellow |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Hemogenyx Pharmaceuticals plc
View source version on accesswire.com:
https://www.accesswire.com/704157/Hemogenyx-Pharmaceuticals-PLC-Announces-Posting-of-Annual-Report-Notice-of-AGM
FAQ
What is Hemogenyx Pharmaceuticals' AGM date in 2022?
Where can I find the Annual Report for Hemogenyx Pharmaceuticals?
What does the 2021 Equity Incentive Plan relate to?